Figure 8.
Analysis of progression-free survival (PFS) between cervical adenosquamous carcinomas (ASCs) versus Human papillomavirus (HPV)-associated ECAs (HPVAs); ASCs versus invasive stratified mucin-producing carcinomas (iSMCs) (pure and with components); iSMCs pure versus iSMCs with components.